Affordable Access

deepdyve-link
Publisher Website

[New biomarkers in prostate cancer].

Authors
  • Provenzano, M
Type
Published Article
Journal
Praxis
Publication Date
Jan 18, 2012
Volume
101
Issue
2
Pages
115–121
Identifiers
DOI: 10.1024/1661-8157/a000819
PMID: 22252593
Source
Medline
License
Unknown

Abstract

Prostate cancer (PCa) is one of the most common solid cancers and one of the most important causes of morbidity and mortality worldwide in men. So far, several efforts have been devoted to identify prostate cancer biomarkers, which allow a discrimination between indolent and clinically significant diseases, however with scarce results. The prostate-specific antigen (PSA) still remains the marker of choice for PCa diagnosis, prognosis, and «active surveillance». Thus, a sensitive and specific independent indicator, easy to screen in blood or urine is still not available. This review will provide a new insight into the role of previous (i.e. PSA) and new biomarkers, to use separately or in combination for prostate cancer screening and early detection programs.

Report this publication

Statistics

Seen <100 times